Biochemical and cell biological studies indicate that Clstn1 could affect degeneration of neural function by influencing Aβ levels in patients suffering from Alzheimer’s disease (Steuble et al., 2012; Vagnoni et al., 2012). This evidence concerns the gene CLSTN1 and Alzheimer disease.